IP Verse

Combination Of Vaccination And Inhibition Of The Pd-1 Pathway

Patent No. EP2958588 (titled "Combination Of Vaccination And Inhibition Of The Pd-1 Pathway") was filed by Curevac on Feb 21, 2014. The application was issued on Aug 23, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ETHERNA IMMUNOTHERAPIESMay 23, 2018ARNOLD & SIEDSMA
MERCK SHARP & DOHMEMay 23, 2018KILBURN & STRODE
STRAWMANMay 23, 2018VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
MODERNAMay 22, 2018HOFFMANN EITLE
SCHNAPPAUFMay 22, 2018-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2958588

CUREVAC
Application Number
EP14706481A
Filing Date
Feb 21, 2014
Status
Revoked
May 24, 2024
Publication Date
Aug 23, 2017
External Links
Slate, Register , Google Patents